Cytomegalovirus retinitis diagnosed after completion of chemotherapy for acute lymphoblastic leukemia in an adolescent

J Pediatr Hematol Oncol. 2015 Mar;37(2):e128-30. doi: 10.1097/MPH.0000000000000252.

Abstract

Although cytomegalovirus (CMV) retinitis is usually diagnosed in allogeneic hematopoietic cell transplantation recipients among patients with hematologic and oncologic disease, it can also occur in acute leukemia patients who have not received hematopoietic cell transplantation. However, CMV retinitis diagnosed after completion of chemotherapy for acute leukemia has not previously been reported. A 17-year-old boy was diagnosed with CMV retinitis 3 months after completion of chemotherapy for acute lymphoblastic leukemia, and his retinitis was assumed to be caused by a delayed immune reconstitution after chemotherapy. The patient was treated with intravenous and intravitreous ganciclovir therapy, and subsequently underwent surgery for retinal detachment.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antiviral Agents / therapeutic use
  • Cytomegalovirus / pathogenicity
  • Cytomegalovirus Retinitis / chemically induced*
  • Cytomegalovirus Retinitis / drug therapy
  • Cytomegalovirus Retinitis / virology
  • Ganciclovir / therapeutic use
  • Humans
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / virology
  • Prognosis

Substances

  • Antiviral Agents
  • Ganciclovir